# What is the influence of exacerbations on pulmonary function in pediatric and adolescent patients with severe asthma despite controller therapies?

**Authors:** A. Z. P. Brandão, L. M. L. B. F. Lasmar, L. M. A. S. Pertence, M. I. R. Vieira, G. B. Lasmar, V. O. Ganem, E. V. Mancuzo, M. V. N. P. de Queiroz

PMC · DOI: 10.1002/clt2.70046 · Clinical and Translational Allergy · 2025-04-04

## TL;DR

This study found that asthma flare-ups in children and teens with severe asthma do not significantly affect lung function when they are on controller treatments.

## Contribution

The study provides new longitudinal evidence on the lack of association between exacerbations and lung function in treated severe pediatric asthma.

## Key findings

- Exacerbations were not significantly associated with changes in FEV1, FEF25–75%, FEV1/FVC, or FVC.
- Passive smoking and being female were linked to lower FEV1 values.
- Most patients (48.5%) experienced at least one exacerbation during the study.

## Abstract

Although exacerbations are common in severe asthma, there have been few longitudinal studies evaluating their effect on lung function parameters. This study aimed to evaluate the impact of exacerbations on lung function in children and adolescents with severe asthma in Brazil.

This was a prospective study in which lung function parameters—forced vital capacity (forced vital capacity [FVC]), forced expiratory volume in 1 s (forced expiratory volume in 1 s [FEV1]), the FEV1/FVC ratio, and the forced expiratory flow between 25% and 75% of FVC (FEF25–75%), each expressed as a percentage of the predicted value—were measured at 3‐month intervals for three years in 64 patients (6–18 years of age) with severe asthma. Multivariate regression models of longitudinal data were employed to assess the associations between exacerbations and other predictors show with lung function parameters.

The mean duration of prior use of an inhaled corticosteroid together with a long‐acting bronchodilator or other controller was 6.7 (SD 3.2) years. During the study period, 31 patients (48.5%) had exacerbations. We analyzed 479 pulmonary function tests and found no significant association between exacerbation and any of the lung function parameters: FEV1 (p = 0.90); FEF25–75% (p = 0.73); FEV1/FVC (p = 0.29); and FVC (p = 0.51). Passive smoking and being female were associated with mean FEV1 values that were 9.89% and 7.32% lower, respectively.

In children and adolescents with severe asthma who are using preventive treatment, exacerbations do not seem to be associated with impaired lung function.

## Linked entities

- **Diseases:** asthma (MONDO:0004979)

## Full-text entities

- **Diseases:** impaired lung function (MESH:D003072), asthma (MESH:D001249)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11971237/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC11971237/full.md

## References

28 references — full list in the complete paper: https://tomesphere.com/paper/PMC11971237/full.md

---
Source: https://tomesphere.com/paper/PMC11971237